SUZHOU, China and ROCKVILLE, Md., May 31, 2020 /PRNewswire/ — Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company…

SHANGHAI, May 31, 2020 /PRNewswire/ — Shanghai Electric, the world’s leading manufacturer and supplier of power generation and industrial equipment, announced upgrades to the company’s digital solution platform SEunicloud in a hope to accelerate the evolution of work and retool the…

CLEVELAND, May 30, 2020 /PRNewswire/ — This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test…

SÃO PAULO, 30 de maio de 2020 /PRNewswire/ — A sociedade foi pega de surpresa a nível mundial e assistiu a interrupção de eventos esportivos internacionais, o fechamento dos maiores parques de diversão do mundo, o cancelamento de uma série de eventos, entre outros acontecimentos diversos….

BUFFALO, N.Y., May 30, 2020 /PRNewswire/ — MimiVax LLC, a clinical-stage biotechnology company in Buffalo, N.Y., USA, developing immunotherapeutics for cancer and autoimmune diseases, announced a clinical collaboration to assess the combination of SurVaxM (MimiVax) and pembrolizumab…

CLEVELAND, May 30, 2020 /PRNewswire/ — This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test from PR Newswire. This is a test…

SINGAPORE, May 30, 2020 /PRNewswire/ — According to the data presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on 29 May 2020, researchers at Samsung Medical Center in Seoul, Korea, have found useful prognostic information beyond actionable biomarkers when the…

ROCKLAND, Mass., May 29, 2020 /PRNewswire/ — EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, today announced that updated data from the ongoing, single-arm Phase II VISION study evaluating tepotinib* as a single agent in patients with…

EAST HANOVER, N.J., May 29, 2020 /PRNewswire/ — Novartis announced today updated results from the landmark COMBI-AD clinical trial, demonstrating that treatment with Tafinlar® (dabrafenib) and Mekinist® (trametinib) following the surgical removal of melanoma offers a long-term and…

MARLBOROUGH, Mass., May 29, 2020 /PRNewswire/ — Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced positive data…